ERS International Congress 2021: highlights from the Allied Respiratory Professionals assembly
- PMID: 35615415
- PMCID: PMC9125039
- DOI: 10.1183/23120541.00674-2021
ERS International Congress 2021: highlights from the Allied Respiratory Professionals assembly
Abstract
This paper provides an overview of some of the most memorable sessions that were (co)organised by the Allied Respiratory Professionals Assembly during the 2021 European Respiratory Society International Congress, which was held online for the second consecutive year due to the COVID-19 pandemic. Early Career Members from Assembly 9 summarised the content of the sessions (three oral communication sessions, two symposia and one Expert View) with the support of the chairs from the four Assembly groups: Respiratory Function Technologists and Scientists (Group 9.01); Physiotherapists (Group 9.02); Nurses (Group 9.03); and Psychologists and Behavioural Scientists (Group 9.04). The sessions covered the following topics: impact of COVID-19 on lung function and healthcare services, and the importance of quality assurance and technology in lung function assessment; diagnosis and management of sarcopenia in patients with chronic respiratory disease; maintenance of the effects of pulmonary rehabilitation; solutions outside the hospital for the management of patients with COVID-19 in need of health care; the nursing perspective during the COVID-19 pandemic; and psychological and behavioural issues in respiratory care. This highlights article provides valuable insight into the latest scientific data and emerging areas affecting clinical practice of allied respiratory professionals.
Copyright ©The authors 2022.
Conflict of interest statement
Conflict of interest: F. Machado declares a PhD grant from Fundação para a Ciência e Tecnologia (reference: SFRH/BD/147200/2019) and support from Bijzonder Onderzoeksfonds – Bilaterale Samenwerking (BOF BILA) from Hasselt University (BOF BILA reference: DOC/SCHLBOSE/190/522). I. Farver-Vestergaard declares payment or honoraria from Boehringer Ingelheim, Novartis and Roche, in the 36 months prior to manuscript submission. K.P. Sylvester declares payment or honoraria from Circassia, Vyaire Medical and NDD Medical Technologies, in the 36 months prior to manuscript submission. A. Šajnić declares unpaid roles as Chair of the European Respiratory Society Nursing Group and as a member of the European Lung Foundation Advisory Professional Committee. J. Cruz declares payment or honoraria from Circassia, Vyaire Medical and NDD Medical Technologies, in the 36 months prior to manuscript submission. All other authors declare no competing interests.
Figures
References
-
- Savushkina O, Cherniak A, Zaitsev A, et al. . Ventilation heterogeneity after COVID-19. Eur Respir J 2021; 58: Suppl. 65, OA2681.
-
- Hurst C, Yearsley S, Stone H, et al. . Evaluation of patient attendance to respiratory physiology in the midst of the COVID-19 Pandemic. Eur Respir J 2021; 58: Suppl. 65, OA2682.
-
- National Health Service Foundation Trust . 2019 Outpatients project – Results published. https://www.nhsbenchmarking.nhs.uk/news/2019-outpatients-project-results.... Date last updated: 17 October 2019. Date last accessed: October 19 2021.
-
- Steenbruggen I, De Laat P, Van De Geijn AHM, et al. . Implementation of the 2017 ERS Methacholine Challenge Standard. Eur Respir J 2021; 58: Suppl. 65, OA2683.
Publication types
LinkOut - more resources
Full Text Sources